Rapid Micro Biosystems, Inc.
RPID
$3.62
-$0.0537-1.46%
NASDAQ
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Revenue | 7.21M | 8.22M | 7.60M | 6.62M | 5.61M |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | 7.21M | 8.22M | 7.60M | 6.62M | 5.61M |
Cost of Revenue | 6.80M | 7.24M | 6.98M | 6.81M | 7.13M |
Gross Profit | 404.00K | 981.00K | 622.00K | -189.00K | -1.52M |
SG&A Expenses | 8.44M | 7.81M | 9.05M | 9.45M | 8.91M |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 18.87M | 18.45M | 19.64M | 20.00M | 19.88M |
Operating Income | -11.66M | -10.23M | -12.04M | -13.38M | -14.27M |
Income Before Tax | -11.26M | -9.68M | -11.31M | -12.56M | -13.32M |
Income Tax Expenses | 7.00K | -9.00K | 13.00K | 15.00K | 3.00K |
Earnings from Continuing Operations | -11.26M | -9.67M | -11.32M | -12.58M | -13.32M |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -11.26M | -9.67M | -11.32M | -12.58M | -13.32M |
EBIT | -11.66M | -10.23M | -12.04M | -13.38M | -14.27M |
EBITDA | -10.91M | -9.46M | -11.38M | -12.55M | -13.57M |
EPS Basic | -0.26 | -0.22 | -0.26 | -0.29 | -0.31 |
Normalized Basic EPS | -0.16 | -0.14 | -0.16 | -0.18 | -0.19 |
EPS Diluted | -0.26 | -0.22 | -0.26 | -0.29 | -0.31 |
Normalized Diluted EPS | -0.16 | -0.14 | -0.16 | -0.18 | -0.19 |
Average Basic Shares Outstanding | 43.99M | 43.77M | 43.67M | 43.62M | 43.25M |
Average Diluted Shares Outstanding | 43.99M | 43.77M | 43.67M | 43.62M | 43.25M |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |